Rep. Lois Frankel sold DuPont de Nemours (DD)
Rep. Lois Frankel (D-FL-22) · $1K–$15K · traded Sep 8, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Sep 8, 2023
- Disclosed
- Oct 10, 2023
- Days to disclose
- 32
- Asset type
- Stock
- As filed
- DuPont de Nemours, Inc.
- Industry
- Chemicals · Basic Materials
Other trades in this filing
All of Frankel's trades →- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
Sold First American Financial FAF
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
Sold The Sherwin-Williams Company SHW
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
Sold Booz Allen Hamilton Holding BAH
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
Sold Broadridge Financial Solutions BR
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$15K–$50K
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$15K–$50K
$15K–$50K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$15K–$50K
$15K–$50K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
- Oct 10, 2023$1K–$15K
$1K–$15K · Traded Sep 8, 2023 · disclosed Oct 10, 2023
Recent Congress trades in DD
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 4, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jul 17, 2026 · disclosed Sep 4, 2026 · filed 49 days later
- Feb 13, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jan 9, 2026 · disclosed Feb 13, 2026
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 12, 2025 · disclosed Dec 15, 2025
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
- Apr 11, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded Mar 31, 2025 · disclosed Apr 11, 2025
- Jul 28, 2023$1K–$15K
Rep. Lois Frankel (D-FL-22)
$1K–$15K · Traded Jun 28, 2023 · disclosed Jul 28, 2023
Company context for DD
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
DD: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
DD: Financial results
Filed 8-K for an event or period dated 2026-11-03. Financial results.
DD: third_quarter 2026 lobbying report
Defense Appropriations FY 2027 FY 2027 Appropriations Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices ITC Investigation Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Section 301 Investigations ITC Investigations Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices
Public: Oct 14, 2026, 4:46 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.